Look Beyond the Hype
Not All AI Is Created Equal
Discover the Unrivaled Power of ProFound AI
Learn More
ProFound AI® Risk
Revolutionizing Personalized Screening
Now available for 2D and 3D mammography
Learn More
<
>
Who is iCAD?
iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
POWERFUL CANCER DETECTION SOLUTIONSInnovative Cancer Therapy solutions
Discover the Unrivaled Power of ProFound AI
Investor Webinar - Replay
Optimizing outcomes and efficiency: iCAD’s world-class solutions for the early detection and treatment of cancer
PLAY WEBINAR
Recent News
January 24, 2022
iCAD’s Breast AI Platform Earns U.S. Department of Defense Authorization to Operate
January 11, 2022
iCAD Announces the Appointment of New Members to its Board of Directors
January 4, 2022
iCAD Announces Estimated Q4 and Fiscal Year 2021 Revenues
December 23, 2021
iCAD to Participate at the 11th Annual LifeSci Partners Virtual Corporate Access Event
December 14, 2021
First Recurrent Glioblastoma Tumor is Treated with Xoft Brain IORT in the United States
» View All News »
Precise and Powerful Healthcare Solutions
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.